TipRanks
Go Ultimate55% OFF

Lishan Aklog Insider Profile

11 Followers

Lishan Aklog, Chairman & CEO, Director at PAVmed, holds 367.57K shares in PAVmed (Ticker: PAVM), holds ― shares in ContraFect (Ticker: CFRXQ), holds 3.64M shares in Lucid Diagnostics (Ticker: LUCD).

Lishan Aklog's Trading History

PAVM
PAVmed
Apr 03, 2026Chairman & CEO, DirectorUninformative Buy―$668.98K
LUCD
Lucid Diagnostics
Feb 24, 2026CEO, DirectorUninformative Buy―$1.49M
PAVMU
PAVmed Inc
Feb 16, 2018―Uninformative Sell―$73.48M
CFRXQ
ContraFect
―Director――

You May Also Like

Lishan Aklog insider profile FAQ

What is the percentage of profitable transactions made by Lishan Aklog?
The percentage of profitable transactions made by Lishan Aklog is 50%.
What is the average return per transaction made by Lishan Aklog?
The average return per transaction made by Lishan Aklog is 12.10%.
What stocks does Lishan Aklog hold?
Lishan Aklog holds: PAVM, CFRXQ, PAVMU, LUCD stocks.
What was Lishan Aklog's most profitable transaction?
Lishan Aklog’s most profitable transaction was an Informative Buy of PAVM stock on May 28, 2019. The return on the trade was 88.50%.
What is Lishan Aklog's role in PAVmed?
Lishan Aklog's role in PAVmed is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.